Allied Biotech Corporation (TPEX:1780)

Allied Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,163	789.08	978.33	618.49	679.75	757.39
Short-Term Investments	53.65	64.83	8.91	106.28	113.25	386.82
Cash & Short-Term Investments	1,216	853.91	987.24	724.77	793	1,144
Cash Growth	12.74%	-13.51%	36.21%	-8.60%	-30.69%	19.27%
Accounts Receivable	165.66	137.95	131.24	109.85	118.54	105.08
Other Receivables	1.55	1.53	1.75	3.6	5.39	4.63
Receivables	167.21	139.48	132.99	113.46	123.92	109.71
Inventory	483.27	511.41	527.54	601.48	596.47	508.09
Other Current Assets	31.16	16.68	15.33	17.17	21.54	23.52
Total Current Assets	1,898	1,521	1,663	1,457	1,535	1,786
Property, Plant & Equipment	565.17	540.7	567.87	594	623.49	625.99
Long-Term Investments	69.73	-	-	0.05	0.73	2.59
Long-Term Deferred Tax Assets	22.82	21.57	16.67	17.37	12.55	15.44
Other Long-Term Assets	1.64	8.05	9.22	10.62	11.31	11.84
Total Assets	2,557	2,092	2,257	2,079	2,183	2,441

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	29.11	31.1	26.66	27.65	38.64	47.21
Accrued Expenses	-	49.8	47.94	35.5	43.78	30.61
Short-Term Debt	700	670	870	700	720	1,110
Current Portion of Long-Term Debt	20.76	18.31	18.31	18.31	18.31	125.99
Current Portion of Leases	4.59	5.05	5.36	5.1	5.49	5.79
Current Income Taxes Payable	25.79	15.12	10.88	16.85	27.46	1.64
Current Unearned Revenue	2.65	1.69	2.6	4.64	1.26	1.59
Other Current Liabilities	218.19	8.98	14.5	20.65	39.84	23.91
Total Current Liabilities	1,001	800.04	996.25	828.69	894.77	1,347
Long-Term Debt	25.3	34.46	52.76	71.07	89.38	-
Long-Term Leases	1.82	4.1	7.74	0.95	3.89	1.03
Pension & Post-Retirement Benefits	8.21	8.95	-	5.92	3.94	9.64
Long-Term Deferred Tax Liabilities	4.95	9.64	4.57	3.49	7.43	2.47
Total Liabilities	1,041	857.19	1,061	910.12	999.4	1,360

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1,091	962.43	960.24	957.85	953.85	953.51
Additional Paid-In Capital	204.44	12.13	9.65	7.74	5.67	5.19
Retained Earnings	211.02	263.95	231.31	209.28	229.88	127.6
Comprehensive Income & Other	9.65	-3.9	-5.67	-6.08	-5.79	-4.79
Shareholders' Equity	1,516	1,235	1,196	1,169	1,184	1,082
Total Liabilities & Equity	2,557	2,092	2,257	2,079	2,183	2,441

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	752.48	731.91	954.17	795.43	837.07	1,243
Net Cash (Debt)	463.77	122	33.07	-70.66	-44.06	-98.6
Net Cash Growth	417.03%	268.93%	-	-	-	-
Net Cash Per Share	4.77	1.27	0.34	-0.74	-0.46	-1.03
Filing Date Shares Outstanding	99.45	96.24	96.02	95.78	95.38	95.35
Total Common Shares Outstanding	99.45	96.24	96.02	95.78	95.38	95.35
Working Capital	896.79	721.44	666.85	628.19	640.17	438.79
Book Value Per Share	15.24	12.83	12.45	12.20	12.41	11.34
Tangible Book Value	1,516	1,235	1,196	1,169	1,184	1,082
Tangible Book Value Per Share	15.24	12.83	12.45	12.20	12.41	11.34
Land	-	210.22	210.22	210.22	210.22	210.22
Buildings	-	290.85	288.9	286.98	258.26	263.3
Machinery	-	981.77	965.22	950.97	915.59	858.72
Construction In Progress	-	14.98	6.07	6.96	42.43	56.22

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 16, 2026

Data Sources Report a data error